Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of pulsed posaconazole enteric-coated tablets for onychomycosis
CTR20262339Phase 3Active
- Sponsor
- XuanTai Pharmaceutical
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of posaconazole in onychomycosis, sponsored by XuanTai Pharmaceutical. Started Aug 2026; status: active.
02
Drugs
posaconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on CTR20262339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262339.